Deep Track Capital, LP Biomarin Pharmaceutical Inc Transaction History

Deep Track Capital, LP

  • $2.71 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$80.93 - $108.63 $44.4 Million - $59.6 Million
-549,063 Reduced 74.31%
189,800 $19.6 Million
Q3 2022

Nov 14, 2022
BUY
$82.16 - $96.94 $6.94 Million - $8.19 Million
84,498 Added 12.91%
738,863 $62.6 Million
Q2 2022

Aug 12, 2022
BUY
$71.48 - $86.85 $46.8 Million - $56.8 Million
654,365 New
654,365 $54.2 Million

Others Institutions Holding BMRN

# of Institutions
635
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email